U.S. Patient Monitoring Systems Market by Component (Device Type, Service Type, and Connectivity Technology Type): Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4058982
- 200 Pages
- August 2020
- Healthcare
Further, IoT applications in healthcare facilitate important tasks such as to improve patient outcomes, and also take some burden off health practitioners. Internet of Things (IoT)-enabled devices have made remote monitoring in the healthcare sector possible, unleashing the potential to keep patients safe and healthy, and empowering physicians to deliver superlative care. Furthermore, growth in IoT healthcare applications is indeed projected to accelerate as the Internet of Things is a key component in the digital transformation of the healthcare industry and various stakeholders are stepping up their effort in this field.
In addition, Patient monitoring devices are used to continuously measure or observe the physiological parameters of a patient. According to a study by Elliot and Coventry, it is important that the following eight parameters of a critically ill patient should be monitored: oxygen saturation, blood pressure, temperature, pain, pulse, level of consciousness, urine output, and respiration rate. All these parameters can be easily monitored with the help of various patient monitoring devices.
Though most of the markets are dropping down, COVID-19 outbreak has positively affected various healthcare related markets, one of them being patient monitoring systems. At present, the patient monitoring systems market is witnessing a tremendous growth. As these are playing a crucial role to combat the pandemic and monitor patients. Patient monitoring systems including cardiac monitors, respiratory devices and temperature monitoring devices are facing a huge demand, owing to their immense usage in patient treatment along with IoT technology. In addition, IoT, specifically and especially when combined with other transformative technologies such as Cloud and Artificial intelligence (AI). This led to wide range of applications of IoT in healthcare during this crisis.
The major factors that contribute toward the growth of the patient monitoring system market include increase in geriatric population, increased adoption of smart devices & wearable’s, and technological advancements. In addition, rising incidence rates of chronic diseases such as COPD, genetic diseases, respiratory diseases, and others also contribute toward uplifting growth of the patient monitoring systems market. Furthermore, collaborations between companies, hospitals, and academic institutions are expected to lead to the launch of new products, which would help to increase the market revenue and boost the market growth. However, data privacy & security issues and lack of awareness among public in developing country like U.S. Moreover, government regulations and reimbursement issues can also hamper growth of the U.S patient monitoring system market.
U.S. PATIENT MONITORING SYSTEM MARKET SEGMENTATION
The U.S. patient monitoring system market is segmented into a component which is further classified into device type is sub-segmented, service type and connectivity technology. By device type sub segmented hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices, fetal neonatal monitoring devices, respiratory monitors, multiparameter monitoring devices, remote patient monitoring devices, and temperature monitoring devices. The service type segment is further divided into consulting, foam dressings, system integration & deployment, and support & maintenance. The connectivity technology type segment is further categorized into cellular IoT, LoRa, NB-IoT, Wi-Fi, SIGFOX, wire line, wireless personal area network (WPAN), and others. Cellular IoT type is further subdivided into 3G and 4G.
Component segment review
On the basis component, the devices segment acquired largest market share in 2019, and is anticipated to maintain to forecast period. The cardiac monitoring devices segment dominated the patient monitoring devices market throughout the forecast period. This is attributed to rise in prevalence of various cardiovascular diseases such as congestive heart failure and stroke each year across the globe.
The report provides a comprehensive analysis of the key players operating in the U.S.
patient monitoring system market, namely Apple Inc., Alphabet Inc. (Google), Abbott Laboratories, Boston Scientific Corporation, International Business Machine Corporation (IBM), General Electric Company, Johnson and Johnson, Nihon Kohden Corporation, Medtronic Plc, Masimo Corporation.
Other players in the patient monitoring system market include (Profiles not included in the report): - Cisco Systems Inc., Koninklijke Philips N.V., Microsoft Corporation, Schiller AG and among others.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current U.S. patient monitoring system market trends and future estimations from 2020 to 2027, which assists in identifying the prevailing market opportunities.
An in-depth analysis of country is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate country specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the U.S. patient monitoring system market is provided.
The key regulatory guidelines for the U.S. patient monitoring system market are critically dealt across the country.
KEY MARKET SEGMENTS
• By Component
• Device
Hemodynamic monitoring devices
Neuromonitoring devices
Cardiac monitoring devices
Fetal neonatal monitoring devices
Respiratory monitors
Multiparameter monitoring devices
Remote patient monitoring devices
Temperature monitoring devices
Others
• Service
Consulting
System Integration and Deployment
Support and Maintenance
• Connectivity Technology
Cellular IoT
• 3G
• 4G
LoRa
NB-IoT
Wi-Fi
SIGFOX
Wireline
Wireless Personal Area Network (WPAN)
Others
1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Top Player Positioning
3.4.Porter’s five forces analysis
3.5.COVID-19 impact on the market
3.6.Government regulations
3.6.1.U.S. FDA
3.7.Reimbursement scenarios
3.8.Clinical trials
3.9.Patent analysis
3.9.1.Patents Registered/Approved, 2011–2020
3.9.2.Patents Registered/Approved, by Applicants, 2011–2020
3.9.3.U.S. patent analysis, by market applicants
3.10.Market Dynamics
3.10.1.Drivers
3.10.1.1.Rise in prevalence of lifestyle diseases
3.10.1.2.Increase in geriatric population
3.10.1.3.Rise in the adoption of remote patient monitoring devices
3.10.2.Restraints
3.10.2.1.Government regulations and reimbursement issues
3.10.2.2.Limited awareness and high costs
3.10.3.Opportunities
3.10.3.1.Technological advancements
CHAPTER 4:PATIENT MONITORING SYSTEMS MARKET, BY COMPONENT
4.1.Overview
4.1.1.Market size and forecast
4.2.Device
4.2.1.Market size and forecast
4.2.2.Hemodynamic monitoring devices
4.2.2.1.Key market trends and opportunity
4.2.2.2.Market size and forecast
4.2.3.Neuromonitoring devices
4.2.3.1.Key market trends and opportunities
4.2.3.2.Market size and forecast
4.2.4.Cardiac monitoring devices
4.2.4.1.Key market trends and opportunities
4.2.4.2.Market size and forecast
4.2.5.Fetal neonatal monitoring devices
4.2.5.1.Key market trends and opportunities
4.2.5.2.Market size and forecast
4.2.6.Respiratory monitors
4.2.6.1.Key market trends and opportunities
4.2.6.2.Market size and forecast
4.2.7.Multiparameter monitoring devices
4.2.7.1.Key market trends and opportunities
4.2.7.2.Market size and forecast
4.2.8.Remote patient monitoring devices
4.2.8.1.Key market trends and opportunities
4.2.8.2.Market size and forecast
4.2.9.Weight monitoring devices
4.2.9.1.Key market trends and opportunities
4.2.9.2.Market size and forecast
4.2.10.Temperature monitoring devices
4.2.10.1.Key market trends and opportunities
4.2.10.2.Market size and forecast
4.2.11.Urine output monitoring
4.2.11.1.Key market trends and opportunities
4.2.11.2.Market size and forecast
4.3.Service
4.3.1.Market size and forecast
4.3.2.Consulting
4.3.2.1.Market size and forecast
4.3.3.System Integration and Deployment
4.3.3.1.Market size and forecast
4.3.4.Support and Maintenance
4.3.4.1.Market size and forecast
4.4.Connectivity Technology
4.4.1.Cellular IoT - 3G
4.4.1.1.Market size and forecast
4.4.2.Cellular IoT - 4G
4.4.2.1.Market size and forecast
4.4.3.Wi-Fi
4.4.3.1.Market size and forecast
4.4.4.SIGFOX
4.4.4.1.Market size and forecast
4.4.5.Wireline
4.4.5.1.Market size and forecast
4.4.6.Wireless Personal Area Network (WPAN)
4.4.6.1.Market size and forecast
4.4.7.Others
4.4.7.1.Market size and forecast
CHAPTER 5:COMPANY PROFILES
5.1.ABBOTT LABORATORIES
5.1.1.Company overview
5.1.2.Company snapshot
5.1.3.Operating business segments
5.1.4.Product portfolio
5.1.5.Business performance
5.1.6.Key strategic moves and developments
5.2.BIOTRONIK SE & CO. KG
5.2.1.Company overview
5.2.2.Company snapshot
5.2.3.Operating business segments
5.2.4.Product portfolio
5.2.5.Key strategic moves and developments
5.3.BOSTON SCIENTIFIC CORPORATION
5.3.1.Company overview
5.3.2.Company snapshot
5.3.3.Operating business segments
5.3.4.Product portfolio
5.3.5.Business performance
5.3.6.Key strategic moves and developments
5.4.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
5.4.1.Company overview
5.4.2.Company snapshot
5.4.3.Operating business segments
5.4.4.Product portfolio
5.4.5.Business performance
5.4.6.Key strategic moves and developments
5.5.F. HOFFMANN-LA ROCHE LTD.
5.5.1.Company overview
5.5.2.Company snapshot
5.5.3.Operating business segments
5.5.4.Product portfolio
5.5.5.Business performance
5.5.6.Key strategic moves and developments
5.6.KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
5.6.1.Company overview
5.6.2.Company snapshot
5.6.3.Operating business segments
5.6.4.Product portfolio
5.6.5.Business performance
5.6.6.Key strategic moves and developments
5.7.MASIMO CORPORATION
5.7.1.Company overview
5.7.2.Company snapshot
5.7.3.Product portfolio
5.7.4.Business performance
5.7.5.Key Strategic Moves and Developments
5.8.MEDTRONIC PLC.
5.8.1.Company overview
5.8.2.Company snapshot
5.8.3.Operating business segments
5.8.4.Medtronic offers following patient monitoring devices
5.8.5.Business performance
5.8.6.Key strategic moves and developments
5.9.NIHON KOHDEN CORPORATION
5.9.1.Company overview
5.9.2.Company snapshot
5.9.3.Operating business segments
5.9.4.Product portfolio
5.9.5.Business performance
5.9.6.Key strategic moves and developments
5.10.OSI Systems, Inc. (Spacelabs Healthcare)
5.10.1.Company overview
5.10.2.Company snapshot
5.10.3.Operating business segments
5.10.4.Product portfolio
5.10.5.Business performance
5.10.6.Key Strategic Moves and Development
TABLE 01.CLINICAL TRIALS: PATIENT MONITORING SYSTEMS MARKET, 2013–2020
TABLE 02.PATENTS REGISTERED/APPROVED ACROSS THE GLOBE, 2011–2020
TABLE 03.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011–2020
TABLE 04.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011- 2020
TABLE 05.U.S. PATIENT MONITORING SYSTEMS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 06.U.S. PATIENT MONITORING SYSTEMS MARKET, BY DEVICE TYPE, 2019–2027 ($MILLION)
TABLE 07.U.S. PATIENT MONITORING SYSTEMS MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)
TABLE 08.ABBOTT: COMPANY SNAPSHOT
TABLE 09.ABBOTT: OERATING SEGMENT
TABLE 10.ABBOTT: PRODUCT PORTFOLIO
TABLE 11.BIOTRONIK: COMPANY SNAPSHOT
TABLE 12.BIOTRONIK: OPERATING SEGMENTS
TABLE 13.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 14.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 15.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 16.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 17.GE: COMPANY SNAPSHOT
TABLE 18.GE: OPERATING SEGMENTS
TABLE 19.GE: PRODUCT PORTFOLIO
TABLE 20.ROCHE: COMPANY SNAPSHOT
TABLE 21.ROCHE: OERATING SEGMENT
TABLE 22.ROCHE: PRODUCT PORTFOLIO
TABLE 23.PHILIPS: COMPANY SNAPSHOT
TABLE 24.PHILIPS: OPERATING SEGMENTS
TABLE 25.PHILIPS: PRODUCT PORTFOLIO
TABLE 26.MASIMO: COMPANY SNAPSHOT
TABLE 27.MASIMO: PRODUCT PORTFOLIO
TABLE 28.MEDTRONIC: COMPANY SNAPSHOT
TABLE 29.MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 30.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 31.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 32.NIHON KOHDEN: PRODUCT PORTFOLIO
TABLE 33.OSI SYSTEMS: COMPANY SNAPSHOT
TABLE 34.OSI SYSTEMS: OPERATING SEGMENTS
TABLE 35.OSI SYSTEMS: PRODUCT PORTFOLIO
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
